Real world experience with Emicizumab in severe haemophilia A (HA) in Senegal, West Africa

被引：0
|
作者：
Diop, Saliou [1 ]
Seck, Moussa [1 ]
Mbomboa, Safiya [1 ]
Martin, Jayson [2 ]
Toure, Sokhna Aissatou [1 ]
Senghor, Alioune Badara [3 ]
Bousso, Elimane Seydi [1 ]
Keita, Mohamed [1 ]
Diallo, Alioune Badara [1 ]
Faye, Blaise Felix [1 ]
Sy, Diariatou [1 ]
Haffar, Assad [2 ]
机构：
[1] Univ Cheikh Anta Diop, Dept Hematol, IHTC Dakar, Dakar, Senegal
[2] World Federat Hemophilia, Montreal, PQ, Canada
[3] Univ Cheikh Anta Diop, Dakar, Senegal
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
Emicizumab; low and middle income countries; prophylaxis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FP-08.04 (
引用
收藏
页码：69 / 70
页数：2
相关论文
共 50 条
  • [21] Real-world data on the use of emicizumab in patients with haemophilia A with and without inhibitors in Singapore
    Lee, Ming Wei
    Cheong, May Anne
    Ng, Heng Joo
    Tien, Sim Leng
    Lam, Joyce Ching Mei
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (11) : 580 - 589
  • [22] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [23] Safety and Outcome of Early Start of Emicizumab in Neonates and Infants with Severe Hemophilia A, a Real-World Experience
    Ahmed, Saad
    Kavanagh, Mary
    Kelly, Imelda
    Ferry, Caitriona
    Mullen, Bertille
    Brady, Bridin
    Nolan, Ruth Hunter
    Nolan, Beatrice
    BLOOD, 2024, 144 : 3976 - 3977
  • [24] Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie
    HAEMOPHILIA, 2020, 26 (04) : 631 - 636
  • [25] Real experience of prophylaxis with emicizumab in patients with congenital haemophilia A with and without FVIII inhibitors in the HCUVA
    Heredia Cano, Angela
    Garcia Candel, Faustino
    Sanchez Villalobos, Maria
    Poveda Garcia, Andrea
    Torchia Esteban, Marcos
    Ruiz Ruiz, Estela
    Sanchez Salas, Jose Antonio
    Navarro Almenzar, Begona
    Caracena Lopez, Sara
    Perez Laencina, Marta
    Blazquez Soto, Juan Antonio
    HAEMOPHILIA, 2024, 30 : 31 - 32
  • [26] Prophylaxis with emicizumab in 50 children and adolescents with severe haemophilia A without inhibitor in Uruguay: National experience
    Lemos, Felipe
    Petraccia, Carlos
    Laura Fraga, Maria
    Gomez, Rosario
    Lutz, Stefani
    Laura Casuriaga, Ana
    Inguanzo, Marianella
    Gonzalez, Jimena
    Echeverria, Silvina
    Gomez, Florencia
    Arocena, Maria
    Gonzalez, Yenirellys
    Giachetto, Gustavo
    Boggia, Beatriz
    HAEMOPHILIA, 2024, 30 : 96 - 97
  • [27] Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making
    Mason, Jane A.
    Young, Guy
    HAEMOPHILIA, 2021, 27 (05) : 724 - 729
  • [28] Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A
    Dunn, A. L.
    Ahuja, S. P.
    Mullins, E. S.
    HAEMOPHILIA, 2018, 24 (03) : E84 - E92
  • [29] EMICIZUMAB PROPHYLAXIS IN ADULT PATIENTS WITH SEVERE HAEMOPHLIA A INHIBITORS: EXPERIENCE FROM A GREEK HAEMOPHILIA CENTRE
    Kouraba, A.
    Zannou, A.
    Gotsi, S.
    Chanos, A.
    Pirpiri, T.
    Kelaidis, E.
    Katsarou, O.
    HAEMATOLOGICA, 2021, 106 (09) : 32 - 32
  • [30] Single dose rFVIIa for severe haemophilia A (HA) with inhibitors: report of the experience in Argentina
    Bianco, R. Perez
    Candela, M.
    Nene, D.
    HAEMOPHILIA, 2010, 16 : 70 - 70
12345